Redpoint Investment Management’s West Pharmaceutical WST Stock Holding History

Redpoint Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$351K	Sell	1,427 -127	-8%	-$38.7K	0.05%	404
2022 Q2	$470K	Sell	1,554 -43	-3%	-$14K	0.06%	384
2022 Q1	$656K	Hold	1,597	–	–	0.07%	346
2021 Q4	$749K	Hold	1,597	–	–	0.06%	360
2021 Q3	$678K	Buy	1,597 +170	+12%	+$71.7K	0.06%	373
2021 Q2	$512K	Hold	1,427	–	–	0.04%	450
2021 Q1	$402K	Hold	1,427	–	–	0.03%	498
2020 Q4	$404K	Hold	1,427	–	–	0.04%	411
2020 Q3	$392K	Buy	1,427 +288	+25%	+$76.2K	0.04%	411
2020 Q2	$259K	Buy	+1,139	New	+$224K	0.01%	518

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redpoint Investment Management's WST Position: Q3 2022 in Review

Redpoint Investment Management reduced its West Pharmaceutical (WST) stake by 8.2% in Q3 2022, selling an estimated $38.7K and leaving 1,427 shares worth $351K. The position accounts for 0.05% of the portfolio, ranked #404.

Redpoint Investment Management first reported a position in WST in Q2 2020 and has held it in 10 quarters since. The position peaked at $749K in Q4 2021. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

Redpoint Investment Management held 1,427 shares of West Pharmaceutical worth $351K as of Q3 2022.
Redpoint Investment Management sold 127 West Pharmaceutical shares in Q3 2022, an estimated $38.7K.
West Pharmaceutical made up 0.05% of Redpoint Investment Management's portfolio in Q3 2022, its #404 holding.
Redpoint Investment Management first reported a position in West Pharmaceutical in Q2 2020 and has held it in 10 quarters since.
Redpoint Investment Management's West Pharmaceutical position peaked at $749K in Q4 2021.
638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.